Hugo Gravel1, Vincent Jacquemet2, Nagib Dahdah3, Daniel Curnier1. 1. Department of Kinesiology, University of Montreal, Montreal, QC, Canada. 2. Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, QC, Canada. 3. Division of Pediatric Cardiology and CHU Ste-Justine Research Center, CHU Ste-Justine, Montreal, QC, Canada.
Abstract
BACKGROUND: QT/RR hysteresis (QT-hys) is an index of the time accommodation of ventricular repolarization to heart rate changes. This report comprehensively reviews studies addressing QT-hys as a biomarker of medical conditions. METHODS: This is a secondary analysis of data from a recent systematic review pertaining to methods of assessment of QT-hys. Articles included in the former review were filtered in order to select original articles investigating the association of QT-hys with medical conditions in humans. RESULTS: Nineteen articles fulfilled our inclusion criteria. Given the heterogeneity of the methods and investigated conditions, no pooled analysis of data could be implemented. QT-hys was mostly studied as a risk marker of severe arrhythmias, as a predictor of the long QT syndrome (LQTS) phenotypes and genotypes and as a marker of exercise-induced ischemia. An increased QT-hys appears to be implicated in arrhythmogenesis, although the evidence in this regard relies on few human studies. An augmented QT-hys was reported in the LQTS, predominantly in the LQT2 genotype, but conflicting results were obtained between studies using different methods of assessment. In addition, QT-hys appears to be a useful marker of stress-induced myocardial ischemia in patients suspected of coronary artery disease. CONCLUSIONS: QT-hys evaluation has potential clinical utility in at least some clinical conditions. Further studies of the clinical validity of QT-hys assessment are warranted, particularly condition specific studies based on QT-hys evaluation methods that provide separate estimates of QT-hys and QT/RR dependency.
BACKGROUND: QT/RR hysteresis (QT-hys) is an index of the time accommodation of ventricular repolarization to heart rate changes. This report comprehensively reviews studies addressing QT-hys as a biomarker of medical conditions. METHODS: This is a secondary analysis of data from a recent systematic review pertaining to methods of assessment of QT-hys. Articles included in the former review were filtered in order to select original articles investigating the association of QT-hys with medical conditions in humans. RESULTS: Nineteen articles fulfilled our inclusion criteria. Given the heterogeneity of the methods and investigated conditions, no pooled analysis of data could be implemented. QT-hys was mostly studied as a risk marker of severe arrhythmias, as a predictor of the long QT syndrome (LQTS) phenotypes and genotypes and as a marker of exercise-induced ischemia. An increased QT-hys appears to be implicated in arrhythmogenesis, although the evidence in this regard relies on few human studies. An augmented QT-hys was reported in the LQTS, predominantly in the LQT2 genotype, but conflicting results were obtained between studies using different methods of assessment. In addition, QT-hys appears to be a useful marker of stress-induced myocardial ischemia in patients suspected of coronary artery disease. CONCLUSIONS: QT-hys evaluation has potential clinical utility in at least some clinical conditions. Further studies of the clinical validity of QT-hys assessment are warranted, particularly condition specific studies based on QT-hys evaluation methods that provide separate estimates of QT-hys and QT/RR dependency.
Authors: Daniel J Pelchovitz; Jason Ng; Alexandru B Chicos; Daniel W Bergner; Jeffrey J Goldberger Journal: Am J Physiol Heart Circ Physiol Date: 2012-04-27 Impact factor: 4.733
Authors: Esther Pueyo; Peter Smetana; Pere Caminal; Antonio Bayes de Luna; Marek Malik; Pablo Laguna Journal: IEEE Trans Biomed Eng Date: 2004-09 Impact factor: 4.538
Authors: Marek Malik; Katerina Hnatkova; Donna Kowalski; James J Keirns; E Marcel van Gelderen Journal: Am J Physiol Heart Circ Physiol Date: 2013-10-25 Impact factor: 4.733
Authors: Gareth J Padfield; Carolina A Escudero; Astrid M DeSouza; Christian Steinberg; Karen Gibbs; Joseph H Puyat; Pei Yoong Lam; Shubhayan Sanatani; Elizabeth Sherwin; James E Potts; George Sandor; Andrew D Krahn Journal: Circulation Date: 2016-01-14 Impact factor: 29.690
Authors: Irena Andršová; Katerina Hnatkova; Kateřina Helánová; Martina Šišáková; Tomáš Novotný; Petr Kala; Marek Malik Journal: Front Physiol Date: 2019-08-02 Impact factor: 4.566
Authors: Katerina Hnatkova; Jose Vicente; Lars Johannesen; Christine Garnett; David G Strauss; Norman Stockbridge; Marek Malik Journal: Sci Rep Date: 2019-10-21 Impact factor: 4.379
Authors: Irena Andršová; Katerina Hnatkova; Martina Šišáková; Ondřej Toman; Peter Smetana; Katharina M Huster; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik Journal: Sci Rep Date: 2021-07-12 Impact factor: 4.996
Authors: Marek Malik; Christine Garnett; Katerina Hnatkova; Jose Vicente; Lars Johannesen; Norman Stockbridge Journal: Drug Saf Date: 2019-03 Impact factor: 5.606
Authors: Marek Malik; Christine Garnett; Katerina Hnatkova; Jose Vicente; Lars Johannesen; Norman Stockbridge Journal: Drug Saf Date: 2019-03 Impact factor: 5.228
Authors: Katerina Hnatkova; Ondřej Toman; Martina Šišáková; Peter Smetana; Katharina M Huster; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik Journal: Sci Rep Date: 2019-12-27 Impact factor: 4.379
Authors: Katerina Hnatkova; Irena Andršová; Ondřej Toman; Peter Smetana; Katharina M Huster; Martina Šišáková; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik Journal: Sci Rep Date: 2021-02-22 Impact factor: 4.379